Canopy logs 68% year-over-year revenue growth in international segment (Video)

By Aurélien BERNARD Canadian cannabis producer Canopy Growth announced a significant improvement in its financial results for the fourth quarter of fiscal year 2026, driven by strong growth in both the medical cannabis sector and its international operations. These results suggest that the restructuring efforts the company has been undertaking for several years may finally be starting to pay off.

Watch Luc Mongeau, CEO of Canopy Growth discuss the company’s fiscal Q4 and full-year 2026 earnings.

Canopy Growth Corp. announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (MTL), a wholly-owned subsidiary of the company....

Canopy Growth today announced Deelish ("DEE-LISH"), a new cannabis brand "built for the everyday consumer with an everyday price." Deelish enters the market with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. The brand will rotate its genetic lineup regularly, giving consumers access to a range of cultivars over time....

Canopy Growth has announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That."

Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's shift towards the medical market....